Population: Adults

Individuals aged 18-64 years

Plaza

Spain
|
2023-2025
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Long-Neuro-COVID-19

Germany
|
2020-2024
  • Adults
  • General population
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

López-González

Spain
|
2021
  • Adults
  • General population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

LoTECA

Norway
|
2021-2022
  • Adults
  • General population
  • Paediatric
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

LUNGTERMcov

Switzerland
|
2021-2023
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

Mailhe

France
|
2022-2022
  • Adults
  • General population
  • Hospital wide
  • Outpatient clinic
  • Monkeypox virus
  • Monkeypox virus infection

MASH-1

United Kingdom France Spain Poland
|
2024-2024
  • Adults
  • Fragile population
  • Immunocompromised host
  • People at high risk of STIs
  • People living with HIV
  • PrEP users
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Monkeypox virus infection

Matias-Guiu

Spain
|
2023-2024
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Mazzitelli

Italy
|
2022-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Molnupiravir

Mazzitelli

Italy
|
2022-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Merad

France
|
2022-2022
  • Adults
  • General population
  • Hospital wide
  • Outpatient clinic
  • Monkeypox virus
  • Monkeypox virus infection
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Merinero

Spain
|
2024-2025
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neurostimulation